Patents Assigned to Shanghai Tianci Life Science Development Co., Ltd.
  • Multi-target peptide molecules of opioid and neuropeptide FF receptor, preparation for molecules, and applications thereof
    Patent number: 11167006
    Abstract: Provided are nine multi-target polypeptides of an opioid and a neuropeptide FF receptor, where an amino acid is replaced on the basis of opioid peptide biphalin- and NPFF-based chimeric peptide BN-9, and acquired are the multi-target polypeptides capable of concurrently activating various opioid and NPFF system receptors.
    Type: Grant
    Filed: April 13, 2017
    Date of Patent: November 9, 2021
    Assignee: Shanghai Tianci Life Science Development Co., Ltd.
    Inventors: Rui Wang, Quan Fang, Zilong Wang, Biao Xu